The ear-nose-throat (ENT) devices market is primed to grow significantly by 2030 owing to the increasing prevalence of ENT disorders around the globe. In addition, notable advancements in ENT technology, along with soaring demand for minimally invasive ENT procedures and the growing population, are likely to propel market growth over the forecast timeline.

During the COVID-19 pandemic, widespread postponement of elective surgeries in order to limit the risk of exposure to the novel coronavirus in hospital settings caused a decline in product demand. Furthermore, high procedural and instrument costs, along with a lack of awareness regarding ENT disorders, have posed a threat to industry growth. However, technological advancements and government funding policies have boosted market expansion.

Major players in the industry have been engaging in product innovation and growth strategies, such as collaborations and partnerships to boost their presence in the sector, thereby propelling the growth of the ENT devices market. For instance, in May 2020, Smith & Nephew, a manufacturer of ENT aids, launched its Tula System for the placement of tympanostomy tubes. The innovation enables surgeons to insert ear tubes in children without administering general anesthesia.

To cite another instance, in April 2022, Starkey, a manufacturer of hearing aids in the ENT devices market, in collaboration with Amazon, a video streaming company, introduced their new technology that connects Starkey’s hearing aids, which are integrated with semiconductor expert MediaTek’s chip technology, to Amazon’s Fire TV cube via Bluetooth to enhance the TV-watching experience of people with hearing disorders.

In another instance, in May 2022, Medtronic, a key ENT device manufacturer, completed the acquisition of Intersect Inc, a sinus implant manufacturer. With the takeover, the firm expanded its ENT portfolio with innovative products devised for sinus procedures to offer better post-operative outcomes and aid in the treatment of nasal polyps.

The ear-nose-throat (ENT) devices market has been bifurcated based on end-use, product, and region.

In terms of product, the ear-nose-throat (ENT) devices market has been divided into nasal splints, surgical ear, nose, and throat (ENT) devices, hearing implants, voice prosthesis devices, diagnostic ear, nose, and throat (ENT) devices, and hearing aids. The voice prosthesis devices segment held more than 6% market share in 2021 as a result of rising number of people suffering from oral cancer and throat cancer worldwide.

With regards to end-use, the ENT devices market has been categorized into ENT clinics, ambulatory surgical centers, hospitals, and homecare. The homecare segment is projected to exhibit around 6% CAGR over the study timeframe. The growth is attributed to the prominent rise in disposable income and growing awareness about ENT products.

In the regional landscape, the Latin America ear-nose-throat (ENT) devices industry accounted for 2% of the overall market revenue in 2021 owing to rising incidences of hearing disorders among the geriatric population.